Navigate Biopharma Services, Inc. Launch Assay For Precise Measurement Of Radioligand Therapy Response In Tumors menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Renzo DiCarlo of BioPharma Services Inc. Presents COVID-19 Vaccine Strategies to Canadian Parliament
April 27, 2021 GMT
TORONTO (BUSINESS WIRE) Apr 27, 2021
Renzo DiCarlo, CEO of BioPharma Services Inc. was proud to be invited to appear as a witness before the House of Commons’ Standing Committee on International Trade, in view of its study entitled
.
As a London School of Economics (LSE) alumnus in stakeholder theory research with 25 years of experience in Pharmaceutical GMP and Medical research, Renzo DiCarlo is uniquely qualified to comment on Canada’s future strategy to manage COVID-19, vaccination cycles and the Variants of Concern (VOC) that are now appearing.
Eurofins Bioanalytical Services launches Surrogate Virus Neutralizing antibody detection assays against the SARS-CoV-2 (COVID-19)
Share Article
Eurofins Bioanalytical Services, a member of Eurofins BioPharma Services, Laboratory Testing division, announces the launch of a Surrogate Virus Neutralization Test (sVNT) antibody assay against the SARS-CoV-2-virus. An alternative to conventional testing with a live virus, this assay is the first neutralizing antibody serology test authorized by the FDA as emergency use authorization (EUA). This innovative assay detects the presence of neutralizing/blocking antibodies against SARS-CoV-2 virus, that block the interaction between the receptor-binding domain (RBD) of the viral spike glycoprotein with the ACE2 cell surface receptor.